Skip to main content
Clinical Trials/NL-OMON54543
NL-OMON54543
Recruiting
Not Applicable

Fluid hydration to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis: the FLUYT-prevent trial. a multicenter randomized controlled superiority trial.;Pancreatic duct stent placement to prevent post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis in patients with unintended PD-wire cannulation: a multicenter prospective cohort - FLUYT-prevent trial FLUYT -2-PDS

Sint Antonius Ziekenhuis0 sites1,108 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
post-ERCP pancreatitis
Sponsor
Sint Antonius Ziekenhuis
Enrollment
1108
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age 18 to 85
  • written informed consent

Exclusion Criteria

  • 1\) Allergy to NSAID\*s or other contraindications 2\) Ongoing acute pancreatitis
  • 3\) Ongoing hypotension, including those with sepsis 4\) Cardiac insufficiency
  • (\>NYHA Class I heart failure) 5\) Renal insufficiency (RI, GFR \<30ml/min) 6\)
  • Active ulcer disease 7\) Severe liver dysfunction: Liver cirrhosis and currently
  • ascites 8\) Respiratory insufficiency (pO2\<60mmHg or 90% despite FiO2 of 30% or
  • requiring mechanical ventilation). 9\) Pregnancy 10\) Hyponatremia (Na\+ levels \<
  • 130mmol/l) 11\) Hypernatremia (Na\+ levels \> 150mmol/l) 12\) Oedema 13\) Low risk
  • of PEP: chronic calcific pancreatitis (according to M\-ANNHEIM criteria) with a
  • CBD intervention (PD intervention is allowed \-\-\> not in FLUYT\-2\-PDS); or
  • pancreatic head mass; or routine biliary stent exchange; or re\-ERCP with a

Outcomes

Primary Outcomes

Not specified

Similar Trials